Global Custom Market Research Reports Provider Company

phone

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review

  • Published Date: 29 Aug 2018
  • Number of Pages: 62
  • Category: SWOT Analysis
  • Country: India
Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. It also provides research services including discovery, development and manufacturing services for both small and large molecules. Biocon provides research solutions to the biotechnology and pharmaceutical companies worldwide. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Biocon is headquartered in Bangalore, Karnataka, India.

Biocon Ltd Key Recent Developments

Jul 26,2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr
Jul 04,2018: Biocons Sterile Drug Product facility Receives EU GMP Certification
Jun 23,2018: Biocons Sterile Drug Product facility Receives EIR from U.S. FDA
May 02,2018: Biocon Regulatory Audit Update
Apr 26,2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma - Biocon Ltd]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Biocon Ltd - Key Facts 6
Biocon Ltd - Key Employees 7
Biocon Ltd - Key Employee Biographies 8
Biocon Ltd - Major Products and Services 9
Biocon Ltd - History 12
Biocon Ltd - Company Statement 17
Biocon Ltd - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Section 2 Company Analysis 22
Company Overview 22
Biocon Ltd - Business Description 23
Business Segment: Biologics 23
Overview 23
Performance 23
Business Segment: Branded Formulations 23
Overview 23
Performance 23
Business Segment: Research Services 24
Overview 24
Performance 24
Business Segment: Small Molecules 24
Overview 24
Performance 24
Geographical Segment: India 24
Performance 24
Geographical Segment: Rest of the World 24
Performance 24
Geographical Segment: United States of America 24
Performance 24
R&D Overview 25
Biocon Ltd - Corporate Strategy 26
Biocon Ltd - SWOT Analysis 27
SWOT Analysis - Overview 27
Biocon Ltd - Strengths 27
Biocon Ltd - Weaknesses 28
Biocon Ltd - Opportunities 29
Biocon Ltd - Threats 30
Biocon Ltd - Key Competitors 31
Section 3 Company Financial Ratios 32
Financial Ratios - Capital Market Ratios 32
Financial Ratios - Annual Ratios 33
Performance Chart 36
Financial Performance 36
Financial Ratios - Interim Ratios 37
Financial Ratios - Ratio Charts 38
Section 4 Companys Lifesciences Financial Deals and Alliances 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40
Biocon Ltd, Recent Deals Summary 41
Section 5 Companys Recent Developments 42
Jul 26, 2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr 42
Jul 04, 2018: Biocons Sterile Drug Product facility Receives EU GMP Certification 45
Jun 23, 2018: Biocons Sterile Drug Product facility Receives EIR from U.S. FDA 46
May 02, 2018: Biocon Regulatory Audit Update 47
Apr 26, 2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma - Biocon Ltd] 48
Mar 13, 2018: Update On Company Statement On US-FDA Inspection At Biocon Malaysia 51
Dec 13, 2017: Biocons Clarification post media reports on Biocon on the FDA list for not paying facility fee 52
Nov 20, 2017: Biocons Drug product Facility Receives EIR with VAI status, Inspection Closed 53
Oct 26, 2017: Biocon Q2FY18 Revenues at Rs 1019 Crore; EBITDA at Rs 233 Crore; Net Profit at Rs 69 Crore 54
Oct 25, 2017: Biocon Ranked Among Top 10 Global Pharma & Biotech Employers 57
Section 6 Appendix 58
Methodology 58
Ratio Definitions 58
About GlobalData 62
Contact Us 62
Disclaimer 62

List Of Tables


Biocon Ltd, Key Facts 6
Biocon Ltd, Key Employees 7
Biocon Ltd, Key Employee Biographies 8
Biocon Ltd, Major Products and Services 9
Biocon Ltd, History 12
Biocon Ltd, Subsidiaries 20
Biocon Ltd, Joint Venture 20
Biocon Ltd, Key Competitors 31
Biocon Ltd, Ratios based on current share price 32
Biocon Ltd, Annual Ratios 33
Biocon Ltd, Annual Ratios (Cont...1) 34
Biocon Ltd, Annual Ratios (Cont...2) 35
Biocon Ltd, Interim Ratios 37
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40
Biocon Ltd, Recent Deals Summary 41
Currency Codes 58
Capital Market Ratios 58
Equity Ratios 59
Profitability Ratios 59
Cost Ratios 60
Liquidity Ratios 60
Leverage Ratios 61
Efficiency Ratios 61

List Of Figures


Biocon Ltd, Performance Chart (2014 - 2018) 36
Biocon Ltd, Ratio Charts 38
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 40

TOP Ships Inc (TOPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report

Allied Motion Technologies, Inc. (AMOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports